SUBSCRIBE
SUBSCRIBE
News   Drug Development

Study Backs Early Use of Johnson & Johnson’s Remicade in Crohn’s

February 22, 2008 | 
1 min read
LONDON, Feb 22 (Reuters) - Treating Crohn's disease by starting people early on drugs that suppress the immune system is more effective than conventional therapy using steroids, according to a study published on Friday.
Clinical research Postmarket research Europe
Johnson & Johnson Family of Companies
MORE ON THIS TOPIC
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Neuropsychiatric disorders
Vistagen in freefall as social anxiety drug fails Phase 3
July 1, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
 · 
2 min read
 · 
Jef Akst
A man and woman on opposite edges of a large chat bubble
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Halftone collage of two hands that untangles tangled ball or messy line. Concept of solving mental problems or simplification of a complex process in business. Vector illustration.
Job Trends
Opinion: Innovation wins the contract. Complexity loses the renewal
July 1, 2026
 · 
3 min read
 · 
Antonio Serrano